ADVANCED BREAST-CANCER - HIGH-DOSE CHEMOTHERAPY AND BONE-MARROW AUTO-TRANSPLANTS

[21] KESSINGER A, 1986, EXP HEMATOL, V14, P192

[22] KESSINGER A, 1986, EXP HEMATOL, V14, P541

[23] KNIGHT WA, 1984, BREAST CANCER RES TR, V4, P336

[24] DIFFERENTIAL REACTIVITY OF A NOVEL MONOCLONAL-ANTIBODY (DF3) WITH HUMAN-MALIGNANT VERSUS BENIGN BREAST-TUMORS [J]. HYBRIDOMA, 1984, 3 (03): : 223 - 232

[25] INTENSIVE MELPHALAN CHEMOTHERAPY AND CRYOPRESERVED AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR TREATMENT OF REFRACTORY CANCER [J]. JOURNAL OF CLINICAL ONCOLOGY, 1983, 1 (06) : 359 - 367

[26] LIVINGSTON RB, 1987, CANCER, V59, P1249, DOI 10.1002/1097-0142(19870401)59:7<1249::AID-CNCR2820590703>3.0.CO

[27] 2-K

[28] MANN SL, 1986, EXP HEMATOL, V14, P541

[29] MARANINCHI D, 1984, MONOGR SER EUR ORGAN, V14, P145

[30] MORECKI S, 1987, BONE MARROW TRANSPL, V1, P357

[21] KESSINGER A, 1986, EXP HEMATOL, V14, P192

[22] KESSINGER A, 1986, EXP HEMATOL, V14, P541

[23] KNIGHT WA, 1984, BREAST CANCER RES TR, V4, P336

[24] DIFFERENTIAL REACTIVITY OF A NOVEL MONOCLONAL-ANTIBODY (DF3) WITH HUMAN-MALIGNANT VERSUS BENIGN BREAST-TUMORS [J]. HYBRIDOMA, 1984, 3 (03): : 223 - 232

[25] INTENSIVE MELPHALAN CHEMOTHERAPY AND CRYOPRESERVED AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR TREATMENT OF REFRACTORY CANCER [J]. JOURNAL OF CLINICAL ONCOLOGY, 1983, 1 (06) : 359 - 367

[26] LIVINGSTON RB, 1987, CANCER, V59, P1249, DOI 10.1002/1097-0142(19870401)59:7<1249::AID-CNCR2820590703>3.0.CO

[27] 2-K

[28] MANN SL, 1986, EXP HEMATOL, V14, P541

[29] MARANINCHI D, 1984, MONOGR SER EUR ORGAN, V14, P145

[30] MORECKI S, 1987, BONE MARROW TRANSPL, V1, P357